James R Hackney
Overview
Explore the profile of James R Hackney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tavakoli M, Isen D, Singhal A, Hackney J
J Neuroophthalmol
. 2022 Apr;
42(2):e527.
PMID: 35483087
No abstract available.
2.
Griguer C, Oliva C, Coffey C, Cudkowicz M, Conwit R, Gudjonsdottir A, et al.
Neurooncol Adv
. 2022 Jan;
4(1):vdab186.
PMID: 35088051
Background: Glioblastoma (GBM) has a 5-year survival rate of 3%-5%. GBM treatment includes maximal resection followed by radiotherapy with concomitant and adjuvant temozolomide (TMZ). Cytochrome C oxidase (CcO) is a...
3.
Salehani A, Mooney J, Lepard J, Hackney J, Harmon D
Neurosurgery
. 2021 Feb;
88(6):E537-E542.
PMID: 33611519
Background And Importance: Ameloblastic carcinoma (AC) is a malignant neoplasm of epithelial origin that typically arises from the mandible or maxilla. It represents approximately 2% of all odontogenic tumors. Gross...
4.
Omar N, Chagoya G, Elsayed G, Litovsky S, Hackney J, Fisher W
Surg Neurol Int
. 2021 Jan;
12:2.
PMID: 33500817
Background: Intravenous (IV) methamphetamine abuse is associated with a variety of short- and long-term effects on the nervous system, some of which have yet to be fully elucidated. One known...
5.
Shen J, Memon A, Hackney J, Sotoudeh H, Fathallah-Shaykh H
Neurohospitalist
. 2020 Sep;
10(4):314-317.
PMID: 32983354
No clear guidelines exist for the appropriate diagnostic workup of an intracranial mass suspected to be a metastasis from unknown primary origin. Dural metastasis from prostatic origin is very rare....
6.
Wang K, Hackney J, Siegal G, Wei S
Clin Breast Cancer
. 2020 May;
20(5):e569-e575.
PMID: 32381383
Background: Receptor activator of nuclear factor κB (RANK) and its ligand, RANKL, are essential for mammary gland development and play a vital role in breast carcinogenesis. RANKL-RANK signaling also drives...
7.
Yamashita D, Bernstock J, Elsayed G, Sadahiro H, Mohyeldin A, Chagoya G, et al.
J Neurosurg
. 2020 Feb;
134(3):721-732.
PMID: 32059178
Objective: Despite an aggressive multimodal therapeutic regimen, glioblastoma (GBM) continues to portend a grave prognosis, which is driven in part by tumor heterogeneity at both the molecular and cellular levels....
8.
Lobbous M, Bernstock J, Coffee E, Friedman G, Metrock L, Chagoya G, et al.
Cancers (Basel)
. 2020 Jan;
12(1).
PMID: 31906320
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that affects children and adults. Individuals with NF1 are at high risk for central nervous system neoplasms including gliomas....
9.
Rotman L, Hackney J, McGrew B, Fisher W, Rozzelle C
J Neurosurg Pediatr
. 2019 May;
24(2):153-158.
PMID: 31125963
Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder that is phenotypically similar to Noonan syndrome and is associated with mutations in BRAF, MEK1, MEK2, and KRAS. The relationship between malignancy...
10.
Eustace N, Anderson J, Langford C, Trummell H, Hicks P, Jarboe J, et al.
Int J Oncol
. 2019 Apr;
54(6):2039-2053.
PMID: 30942445
Glioblastoma harbors frequent alterations in receptor tyrosine kinases, phosphatidylinositol‑3 kinase (PI3K) and phosphatase and tensin homolog (PTEN) that dysregulate phospholipid signaling driven tumor proliferation and therapeutic resistance. Myristoylated alanine‑rich C‑kinase...